The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Luminal A Breast Cancer and Molecular Assays: A Review
Open accessAbstract
Purpose: Chemotherapy has been the historical mainstay of treatment for patients with breast cancer, with immunohistochemical markers and tumor characteristics driving treatment decisions. The discovery of different intrinsic subtypes of breast cancer has advanced the understanding of breast cancer, with gene-based assays shedding further light on tumor behavior and response to treatment. Design: This review focuses on the landscape of the luminal A subtype, its definition based on immunohistochemistry (IHC) and gene assays, the prognostic and predictive value of these assays, guideline recommendations, and treatment implications. Results: Clinical studies of the prognostic value of gene-based and IHC-based assays in patients with luminal A-subtype breast cancers suggest a better prognosis for these patients compared with those with breast cancers of other subtypes. Conclusion: In today's era of precision medicine, the best treatment regimen for patients with luminal A-subtype tumors is still undetermined, but available data raise the question whether chemotherapy can be omitted and endocrine therapy alone is sufficient for this patient population. Implications for Practice: Immunohistochemical markers have traditionally guided treatment decisions in breast cancer. However, advances in gene-expression profiling and availability of gene-based assays have launched these newer tests into everyday clinical practice. Luminal A-subtype tumors are a unique subset that may have favorable tumor biology. Properly defining this tumor subtype is important and may identify a subset of patients for whom endocrine therapy alone is sufficient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Goldhirsch, A., Winer, E. P., Coates, A. S., Gelber, R. D., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., Albain, K. S., André, F., Bergh, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt303 · Cited by 3,746
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Cardoso, F., van’t Veer, L. J., Bogaerts, J., Slaets, L., Viale, G., Delaloge, S., Pierga, J.-Y., Brain, E., Causeret, S., DeLorenzi, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602253 · Cited by 1,994
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., Zackrisson, S., & Cardoso, F. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv298 · Cited by 1,597
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Perez, E. A., Olson, J. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510764 · Cited by 1,388
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
Clinical implications of the intrinsic molecular subtypes of breast cancer
Prat, A., Pineda, E., Adamo, B., Galván, P., Fernández, A., Gaba, L., Díez, M., Viladot, M., Arance, A., & Muñoz, M. (2015) · The Breast · doi:10.1016/j.breast.2015.07.008 · Cited by 1,319
Buyse, M., Loi, S., van't Veer, L., Viale, G., Delorenzi, M., Glas, A. M., Saghatchian d'Assignies, M., Bergh, J., Lidereau, R., Ellis, P., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj329 · Cited by 1,238
Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H.-J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx308 · Cited by 1,205
Harris, L. N., Ismaila, N., McShane, L. M., Andre, F., Collyar, D. E., Gonzalez-Angulo, A. M., Hammond, E. H., Kuderer, N. M., Liu, M. C., Mennel, R. G., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.2289 · Cited by 811
Dowsett, M., Cuzick, J., Wale, C., Forbes, J., Mallon, E. A., Salter, J., Quinn, E., Dunbier, A., Baum, M., Buzdar, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.4798 · Cited by 724
Dowsett, M., Sestak, I., Lopez-Knowles, E., Sidhu, K., Dunbier, A. K., Cowens, J. W., Ferree, S., Storhoff, J., Schaper, C., & Cuzick, J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.1558 · Cited by 621
Ellis, M. J., Suman, V. J., Hoog, J., Lin, L., Snider, J., Prat, A., Parker, J. S., Luo, J., DeSchryver, K., Allred, D. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6950 · Cited by 551
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Wallden, B., Storhoff, J., Nielsen, T., Dowidar, N., Schaper, C., Ferree, S., Liu, S., Leung, S., Geiss, G., Snider, J., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0129-6 · Cited by 542
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Partridge, A. H., Hughes, M. E., Warner, E. T., Ottesen, R. A., Wong, Y.-N., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.8013 · Cited by 473
Sgroi, D. C., Sestak, I., Cuzick, J., Zhang, Y., Schnabel, C. A., Schroeder, B., Erlander, M. G., Dunbier, A., Sidhu, K., Lopez-Knowles, E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70387-5 · Cited by 399
Krop, I., Ismaila, N., Andre, F., Bast, R. C., Barlow, W., Collyar, D. E., Hammond, M. E., Kuderer, N. M., Liu, M. C., Mennel, R. G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.0472 · Cited by 315
Natural and therapy-induced immunosurveillance in breast cancer
Kroemer, G., Senovilla, L., Galluzzi, L., André, F., & Zitvogel, L. (2015) · Nature Medicine · doi:10.1038/nm.3944 · Cited by 310
Chia, S. K., Bramwell, V. H., Tu, D., Shepherd, L. E., Jiang, S., Vickery, T., Mardis, E., Leung, S., Ung, K., Pritchard, K. I., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0286 · Cited by 302
Prat, A., Carey, L. A., Adamo, B., Vidal, M., Tabernero, J., Cortés, J., Parker, J. S., Perou, C. M., & Baselga, J. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju152 · Cited by 233
Ingold Heppner, B., Untch, M., Denkert, C., Pfitzner, B. M., Lederer, B., Schmitt, W., Eidtmann, H., Fasching, P. A., Tesch, H., Solbach, C., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2338 · Cited by 200
Klein, M. E., Dabbs, D. J., Shuai, Y., Brufsky, A. M., Jankowitz, R., Puhalla, S. L., & Bhargava, R. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.36 · Cited by 196
Molecular Profiling for Breast Cancer: A Comprehensive Review
Kittaneh, M., Montero, A. J., & Glück, S. (2013) · Biomarkers in Cancer · doi:10.4137/bic.s9455 · Cited by 190
Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects
Jatoi, I., Anderson, W. F., Jeong, J.-H., & Redmond, C. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.3550 · Cited by 172
The molecular diversity of Luminal A breast tumors
Ciriello, G., Sinha, R., Hoadley, K. A., Skanderup, A. J., Reva, B. A., Perou, C. M., Sander, C., & Schultz, N. D. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2699-3 · Cited by 162
Krijgsman, O., Roepman, P., Zwart, W. T., Carroll, J. S., Tian, S., de Snoo, F. A., Bender, R. A., Bernards, R., & Glas, A. M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1683-z · Cited by 153
Rosenberg, P. S., Barker, K. A., & Anderson, W. F. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv159 · Cited by 142
Liu, F., Shi, W., Done, S. J., Miller, N. A., Pintilie, M., Voduc, D. K., Nielsen, T. O., Nofech‐Mozes, S., Chang, M. C., Whelan, T. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.7999 · Cited by 135
Prat, A., Cheang, M. C. U., Galván, P., Nuciforo, P. G., Paré, L., Adamo, B., Muñoz-Mateu, M., Viladot, M., Press, M. F., Gagnon, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0922 · Cited by 134
Esserman, L. J., Yau, C. S. F., Thompson, C. K., Veer, L. V. ‘., Borowsky, A. D., Hoadley, K. A., Tobin, N. P., Nordenskjöld, B. A., Fornander, T., Stål, O., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1261 · Cited by 131
Glück, S., Snoo, F. D., Peeters, J. K., Stork‐Sloots, L., & Somlo, G. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2572-4 · Cited by 100
Tobin, N. P., Harrell, J. C., Lövrot, J., Brage, S., Stolt, M. F., Carlsson, L. M. S., Einbeigi, Z., Linderholm, B. K., Loman, N., Malmberg, M., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu498 · Cited by 99
Whitworth, P. W., Stork‐Sloots, L., de Snoo, F. A., Richards, P. D., Rotkis, M. C., Beatty, J. D., Mislowsky, A. M., Pellicane, J. V., Nguyen, B., Lee, L. J., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3908-y · Cited by 95
on behalf of the Austrian Breast and Colorectal Cancer Study group (ABCSG), Fitzal, F., Filipits, M., Rudas, M., Greil, R., Dietze, O., Samonigg, H., Lax, S., Herz, W., Dubsky, P. C., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.98 · Cited by 78
Stover, D. G., Coloff, J. L., Barry, W. T., Brugge, J. S., Winer, E. P., & Selfors, L. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0471 · Cited by 78
Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer
Santarpia, L., Bottai, G., Kelly, C. M., Győrffy, B., Székely, B., & Pusztai, L. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0369 · Cited by 62
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer
Kim, H.-S., Umbricht, C. B., Illei, P. B., Cimino‐Mathews, A., Cho, S., Chowdhury, N., Magalhães, M. C. F., Pesce, C. E., Jeter, S. C., Mylander, C. W., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.7195 · Cited by 60
Prat, A., Lluch, A. M., Turnbull, A., Dunbier, A. K., Calvo, L., Albanell, J., de la Haba-Rodríguez, J., Arcusa, À., Chacón, J. I., Sánchez‐Rovira, P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2092 · Cited by 54
Minicozzi, P., Bella, F., Toss, A., Giacomin, A., Fusco, M., Zarcone, M., Tumino, R., Falcini, F., Cesaraccio, R., Candela, G., et al. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1478-1 · Cited by 48
Rocca, A., Farolfi, A., Maltoni, R., Carretta, E., Melegari, E., Ferrario, C., Cecconetto, L., Sarti, S., Schirone, A., Fedeli, A., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3423-2 · Cited by 31
Chen, J., Peng, J. C., Wang, H.-J., Zhang, J., Xu, Y., Guo, M., Zhang, B., Tang, C., Cao, H., & Wang, S. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-212 · Cited by 19
Ejlertsen, B., Jensen, M., Elversang, J., Rasmussen, B. B., Andersson, M., ANDERSEN, J. E., Nielsen, D. L., Cold, S., & Mouridsen, H. T. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.05.006 · Cited by 7
Cited by
Breast Cancer Treatments: Updates and New Challenges
Burguin, A., Diorio, C., & Durocher, F. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080808 · Cited by 488
Haque, W., Verma, V., Hatch, S., Suzanne Klimberg, V., Brian Butler, E., & Teh, B. S. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4801-3 · Cited by 376
Breast cancer heterogeneity and its implication in personalized precision therapy
Guo, L., Kong, D., Liu, J., Zhan, L., Luo, L., Zheng, W., Zheng, Q., Chen, C., & Sun, S. (2023) · Experimental Hematology & Oncology · doi:10.1186/s40164-022-00363-1 · Cited by 327
Metadata
- Authors
- Gao, J. J., & Swain, S. M.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-22
- Volume
- 23
- Issue
- 5
- Pages
- 556-565
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2789230893
- Cited by
- 254
- References
- 52
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.